12900 Results (Page 298 of 516)
All Market Research Reports
Germany Multiple Myeloma Therapeutics Market Analysis
Germany's Multiple Myeloma Therapeutics Market was valued at $305 Mn in 2022 and is estimated to expand at a CAGR of 2.7% from 2022-30 and will reach $378 Mn in 2030. One of the main reasons propelling the growth of this Market is an increase in chronic disease, Increasing adoption of combination therapies. The Market is segmented by type, drug and distribution channel. Some key players in this Market are Abbott, MorphoSys, Merck, Medigene, Affimed, Helios Hospital, Vivantes Hospital Group and others.
Australia Diabetes Devices Market Analysis
Australian Diabetes Devices Market is expected to witness growth from $273 Mn in 2022 to $532 Mn in 2030 with a CAGR of 8.70% for the forecasted year 2022-30. In Australia, the market for diabetes devices is expanding as a result of the rise in the number of people with the condition and the demand for diabetes devices that can assist people in managing their condition. The market is segmented by type and by the end user. Some key players in this market include Fairmont Medical Products, Cook Medical Australia, Johnson & Johnson, Medtronic, Roche, Ascensia diabetes care, and Dexcom.
Australia Cancer Immunotherapy Market Analysis
Australia's cancer immunotherapy market is expected to grow from $1.35 Bn in 2022 to $2.61 Bn in 2030 with a CAGR of 8.6% for the forecasted year 2022-30. The rising incidence of cancer cases and supportive government programs to promote cancer immunotherapy in Australia are responsible for the growth of the market. The Australian cancer immunotherapy market is segmented by type, application, and end user. Bioarc, Pharmaxis, and Bristol-Myers Squibb are the major players in the Australian cancer immunotherapy market.
Australia Anemia Drugs Market Analysis
Australia's Anemia drugs market was valued at $192 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 10.4% from 2022 to 2030 and will reach $423 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and awareness among people in Australia. The market is segmented by type, drug, and distribution channel. Some key players in this market are Pfizer, Roche, Sanofi, Novartis, Merck, Novo Nordisk, Otsuka, and Baxter among others.
Argentina Medical Devices Market Analysis
This report presents a strategic analysis of the Argentina Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Argentina Medical Devices Market, offering unmatched value, accuracy, and expert insights.
Argentina Diabetes Devices Market Analysis
This report presents a strategic analysis of the Argentina Diabetes Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Argentina Diabetes Devices Market, offering unmatched value, accuracy, and expert insights.
Algeria Home Healthcare Market Analysis
Algeria's home healthcare market was valued at $725 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.93% from 2022 to 2030 and will reach $1335 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the aging population. The market is segmented by component and service. Some key players in this market are Santé dar Home Healthcare, Alrayane Home Healthcare, Sarl megawell Home Healthcare, The Haouari Family Home Healthcare, and many others.
Algeria Healthcare Insurance Market Analysis
This report presents a strategic analysis of the Algeria Healthcare Insurance Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Algeria Healthcare Insurance Market, offering unmatched value, accuracy, and expert insights.
Global Cardiovascular Drugs Market Analysis
The global cardiovascular drug market size is at around $55.32 Bn in 2022 and is projected to reach $78.791 Bn in 2030, exhibiting a CAGR of 4.52% during the forecast period. The rising public awareness of cardiovascular health and the associated rise in product introductions are two major factors contributing to the growth of the Global market for cardiovascular medications. Some of the biggest cardiovascular drug companies in the world are Pfizer Inc., Gilead Sciences, Inc., Bristol-Myers Squibb Company, and Novartis AG.
Algeria Clinical Diagnostics Market Analysis
This report presents a strategic analysis of the Algeria Clinical Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Algeria Clinical Diagnostics Market, offering unmatched value, accuracy, and expert insights.
Global Breast Cancer Therapeutics Market Analysis
With an increase in breast cancer cases worldwide and rising investments in the research and development projects for breast cancer treatment, the Global breast cancer therapeutics market is expected to grow from $18.2 Bn in 2022 to $48.04 Bn in 2030 with a CAGR of 12.9% for the year 2022-2030. The market is segmented by therapy, by cancer type, and by distribution channel. Some of the key market players in the Global breast cancer therapeutics market are Sanofi, Pfizer, and AstraZeneca.
APAC Neurology Devices Market Analysis
APAC Neurology Devices Market is expected to witness growth from $2.65 Bn in 2022 to $5.30 Bn in 2030 with a CAGR of 9.07% for the forecasted year 2022-2030. The APAC neurology devices market is anticipated to expand at the highest rates of all the continents due to its enormous patient base, which includes a sizable number of people suffering from neurovascular illnesses that harm the human brain. The demand for neurology devices in the APAC area is being driven by the region's aging population and the rising incidence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and stroke. The market is segmented by product type and by the end user. Some key players in the market include Johnson and Johnson, GE Healthcare, Stryker, and Medtronic.
APAC Home Healthcare Market Analysis
APAC home healthcare market was valued at $76.15 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.2% from 2022-30 and will reach $153.98 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the ageing population. The market is segmented by component and product. Some key players in this market are BestCare 24 (AUS), Portea Medical (IND), Healthcare at HOME (IND), Doctor Mate (JPN), Medtronic Japan (JPN), and many others.
APAC HIV Drugs Market Analysis
This report presents a strategic analysis of the APAC HIV Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the APAC HIV Drugs Market, offering unmatched value, accuracy and expert insights.
Vietnam Oncology Clinical Trials Market Analysis
Vietnam's oncology clinical trials market is projected to grow from $63.3 Mn in 2022 to $98.8 Mn by 2030, registering a CAGR of 5.73% during the forecast period of 2022-30. The market will be driven by the big and diversified patient population available for clinical trials and a well-established clinical trial regulatory structure. The market is segmented by phase, by study design & by indication. Some of the major players include AstraZeneca PLC, Novartis AG & Hau Giang Pharmaceutical Joint Stock Company.
Vietnam Digital Health Market Analysis
Vietnam's Digital Health market is projected to grow from $xxBn in 2022 to $xxBn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by government support and the increasing use of technology in healthcare. The market is segmented by solution, by deployment & by end-use. Some of the major players include Jio Health, eDoctor & Thuocsi.
US Neurology Clinical Trials Market Analysis
The US neurology clinical trials market is projected to grow from $2.20 Bn in 2022 to $2.89 Bn by 2030, registering a CAGR of 3.5% during the forecast period of 2022-30. The prevalence of neurological disorders in the US is on the rise, with an aging population and changing lifestyles being significant contributors. As a result, there is a growing need for effective treatments and therapies to manage and treat these conditions, leading to an increase in neurology clinical trials. The US neurology clinical trials market is expected to grow significantly in the coming years, driven by an increasing prevalence of neurological disorders, a growing aging population, and advancements in technology and treatments.
US Clinical Trials Support Service Market Analysis
The US clinical trials support services market is projected to grow from $8.76 Bn in 2022 to $13.24 Bn by 2030, registering a CAGR of 5.3% during the forecast period of 2022-30. The high burden of infectious and chronic diseases in emerging economies, pharmaceutical companies' high R&D spending, an increase in the number of contract research organizations, and the prevalence of diseases are the main drivers of the market's expansion. The major key players in the market are Charles River Labs, Covance, Syneos Health, etc.
US Advanced Therapy Medicinal Products (ATMPs) Market Analysis
The US Advanced Therapy Medicinal Products (ATMPs) market is projected to grow from $4.3 Bn in 2022 to $9.8 Bn by 2030, registering a CAGR of 11% during the forecast period of 2022-30. One of the key drivers of growth in the US ATMP market is the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. These diseases often require long-term treatment, and ATMPs offer a promising new approach to treating them. Additionally, advances in gene editing technologies such as CRISPR/Cas9 have increased the potential for ATMPs to cure genetic disorders. Some of the major players are Novartis International AG, Gilead Sciences, Inc., Bluebird Bio, Inc., Spark Therapeutics, Inc., and Kite Pharma, Inc.
UK Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the UK Lung Cancer Therapeutics Market will reach a value of $1245 Mn from $775 Mn in 2022, growing at a CAGR of 6.1% during 2022-30. The Lung Cancer Therapeutics Market in the UK is dominated by a few domestic pharmaceutical companies such as Scancell, Sareum Holdings, and AstraZeneca. The Lung Cancer Therapeutics Market in the UK is segmented into different types of cancer and different therapy types. Some of the major factors affecting the UK lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
UK Diabetes Therapeutics Market Analysis
The UK diabetes therapeutics market is expected to grow from $3.74 Bn in 2022 to $6.77 Bn in 2030 with a CAGR of 7.7% for the forecasted year 2022-30. The rising incidence of diabetes and the subsequent demand for new and innovative treatment options for diabetes in the UK is driving the growth of the market. The UK diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Tanner Pharma, Bracco, and AstraZeneca are the major players in the UK diabetes therapeutics market.
UK Diabetes Devices Market Analysis
The UK Diabetes Devices Market is expected to witness growth from $591 Mn in 2022 to $887 Mn in 2030 with a CAGR of 5.20% for the forecasted year 2022-30. Diabetes is becoming more common in the UK, which is raising the demand for diabetes devices. Continuous glucose monitoring systems and flash glucose monitoring systems are two examples of non-invasive and slightly invasive diabetes devices that are in increasing demand in the UK. The market is segmented by type and by the end user. Some key players in this market include Magstim, Deltex Medical, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
UK Dental Care Market Analysis
The UK dental care market size is at around $933 Mn in 2022 and is projected to reach $1,317 Mn in 2030, exhibiting a CAGR of 4.4% during the forecast period. 18% of the population has experienced one or more of the following oral problems: trouble pronouncing words, difficulty eating, embarrassment, self-consciousness, or terrible hurting in the mouth and 23.4% of 5-year-old children in England had experienced of dental decay. The report by Insights10 is segmented by treatment type, age group, clinical setup and demography and provides in-depth market insights.
UK 3D Imaging Market Analysis
The UK 3D imaging market is projected to grow from $0.79 Bn in 2022 to $2.33 Bn by 2030, registering a CAGR of 14.5% during the forecast period of 2022-30. The market will be driven by technological advancements and government initiatives to promote the same. The market is segmented by product, application, end-user & by portability. Some of the major players include Philips Healthcare, GE Healthcare & Vision RT Ltd.
UAE Pharmaceutical Market Analysis
This report presents a strategic analysis of the UAE Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UAE Pharmaceutical Market, offering unmatched value, accuracy and expert insights.